CHE vs LEN
Chemed Corp (CHE) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Chemed Corp (CHE) is a medical care facilities company listed on NYSE.
LEN (LEN) common stock.
Latest reported CHE revenue for 2024-12-31 was $2.43B. Net income was $302.0M. Revenue was up 7.4% from 2023-12-31 to 2024-12-31. CHE currently screens at market cap $5.79B and trailing P/E 23.8.
LEN does not have a complete income-statement cache yet.
CHE currently screens at market cap $5.79B and trailing P/E 23.8. LEN currently screens at market cap $0.
Not investment advice. Open the CHE and LEN stock pages for the full models.
Not investment advice.